LIP
IDXX icon

Liontrust Investment Partners’s Idexx Laboratories IDXX Stock Holding History

Liontrust Investment Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113M Buy
215,198
+37,861
+21% +$21.2M 1.66% 18
2026
Q1 		$99.6M Buy
177,337
+26,557
+18% +$17M 1.7% 19
2025
Q4 		$102M Sell
150,780
-14,912
-9% -$10.2M 1.51% 23
2025
Q3 		$106M Sell
165,692
-9,888
-6% -$6M 1.55% 25
2025
Q2 		$94.2M Sell
175,580
-12,049
-6% -$5.76M 1.35% 33
2025
Q1 		$78.8M Buy
187,629
+181,682
+3,055% +$78.9M 1.23% 34
2024
Q4 		$2.46M Buy
+5,947
New +$2.61M 0.04% 139

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Liontrust Investment Partners's IDXX Position: Q2 2026 in Review

Liontrust Investment Partners increased its Idexx Laboratories (IDXX) stake by 21% in Q2 2026, buying an estimated $21.2M and bringing the position to 215,198 shares worth $113M. The position accounts for 1.66% of the portfolio, ranked #18.

Liontrust Investment Partners first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Liontrust Investment Partners held 215,198 shares of Idexx Laboratories worth $113M as of Q2 2026.
  • Liontrust Investment Partners bought 37,861 Idexx Laboratories shares in Q2 2026, an estimated $21.2M.
  • Idexx Laboratories made up 1.66% of Liontrust Investment Partners's portfolio in Q2 2026, its #18 holding.
  • Liontrust Investment Partners first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Liontrust Investment Partners's 13F filing for Q2 2026, filed 18 Aug 2026.